nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—ABCB11—Rifampicin—leprosy	0.211	0.238	CbGbCtD
Daunorubicin—ABCC1—Rifampicin—leprosy	0.15	0.169	CbGbCtD
Daunorubicin—ABCC2—Rifampicin—leprosy	0.111	0.125	CbGbCtD
Daunorubicin—CYP1A1—Thalidomide—leprosy	0.0955	0.108	CbGbCtD
Daunorubicin—CYP3A5—Thalidomide—leprosy	0.0573	0.0648	CbGbCtD
Daunorubicin—CYP3A5—Rifampicin—leprosy	0.0555	0.0627	CbGbCtD
Daunorubicin—CYP3A5—Dapsone—leprosy	0.0458	0.0518	CbGbCtD
Daunorubicin—CYP1A2—Thalidomide—leprosy	0.0426	0.0482	CbGbCtD
Daunorubicin—CYP1A2—Rifampicin—leprosy	0.0413	0.0467	CbGbCtD
Daunorubicin—ABCB1—Rifampicin—leprosy	0.0361	0.0408	CbGbCtD
Daunorubicin—CYP3A4—Rifampicin—leprosy	0.0216	0.0245	CbGbCtD
Daunorubicin—CYP3A4—Dapsone—leprosy	0.0179	0.0202	CbGbCtD
Daunorubicin—Myelodysplastic syndrome—Thalidomide—leprosy	0.00611	0.0646	CcSEcCtD
Daunorubicin—TOP2B—Menadione—Thalidomide—leprosy	0.00493	0.861	CbGdCrCtD
Daunorubicin—Meningitis—Thalidomide—leprosy	0.00316	0.0334	CcSEcCtD
Daunorubicin—Pericarditis—Thalidomide—leprosy	0.00284	0.03	CcSEcCtD
Daunorubicin—Febrile neutropenia—Thalidomide—leprosy	0.00204	0.0215	CcSEcCtD
Daunorubicin—Nail disorder—Thalidomide—leprosy	0.00189	0.02	CcSEcCtD
Daunorubicin—Liver disorder—Thalidomide—leprosy	0.0018	0.019	CcSEcCtD
Daunorubicin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.0018	0.019	CcSEcCtD
Daunorubicin—Hepatomegaly—Thalidomide—leprosy	0.00173	0.0183	CcSEcCtD
Daunorubicin—Viral infection—Thalidomide—leprosy	0.00136	0.0143	CcSEcCtD
Daunorubicin—Cellulitis—Thalidomide—leprosy	0.00135	0.0142	CcSEcCtD
Daunorubicin—Thinking abnormal—Thalidomide—leprosy	0.00134	0.0142	CcSEcCtD
Daunorubicin—Hyperuricaemia—Thalidomide—leprosy	0.00132	0.014	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Dapsone—leprosy	0.00131	0.0139	CcSEcCtD
Daunorubicin—Atrioventricular block—Thalidomide—leprosy	0.00126	0.0134	CcSEcCtD
Daunorubicin—Sinusitis—Dapsone—leprosy	0.00126	0.0133	CcSEcCtD
Daunorubicin—Gait disturbance—Thalidomide—leprosy	0.00126	0.0133	CcSEcCtD
Daunorubicin—Blood uric acid increased—Thalidomide—leprosy	0.00125	0.0132	CcSEcCtD
Daunorubicin—Neuropathy—Thalidomide—leprosy	0.00115	0.0122	CcSEcCtD
Daunorubicin—Tinnitus—Dapsone—leprosy	0.00112	0.0119	CcSEcCtD
Daunorubicin—Oesophagitis—Thalidomide—leprosy	0.00112	0.0118	CcSEcCtD
Daunorubicin—Hypertonia—Thalidomide—leprosy	0.00107	0.0114	CcSEcCtD
Daunorubicin—Hyperkinesia—Thalidomide—leprosy	0.00107	0.0113	CcSEcCtD
Daunorubicin—Mental disability—Thalidomide—leprosy	0.00106	0.0112	CcSEcCtD
Daunorubicin—Erythema—Dapsone—leprosy	0.00105	0.0111	CcSEcCtD
Daunorubicin—Lymphadenopathy—Thalidomide—leprosy	0.00104	0.011	CcSEcCtD
Daunorubicin—Thrombophlebitis—Thalidomide—leprosy	0.00103	0.0109	CcSEcCtD
Daunorubicin—Deafness—Thalidomide—leprosy	0.000995	0.0105	CcSEcCtD
Daunorubicin—Eye pain—Thalidomide—leprosy	0.000986	0.0104	CcSEcCtD
Daunorubicin—Cardiac failure congestive—Thalidomide—leprosy	0.000982	0.0104	CcSEcCtD
Daunorubicin—ABCC6—eye—leprosy	0.000968	0.0655	CbGeAlD
Daunorubicin—Increased appetite—Thalidomide—leprosy	0.000948	0.01	CcSEcCtD
Daunorubicin—Amnesia—Thalidomide—leprosy	0.000948	0.01	CcSEcCtD
Daunorubicin—Atrial fibrillation—Thalidomide—leprosy	0.000939	0.00993	CcSEcCtD
Daunorubicin—Cough—Dapsone—leprosy	0.000914	0.00966	CcSEcCtD
Daunorubicin—Cardiac failure—Thalidomide—leprosy	0.000912	0.00964	CcSEcCtD
Daunorubicin—YWHAG—eye—leprosy	0.000912	0.0617	CbGeAlD
Daunorubicin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00089	0.00941	CcSEcCtD
Daunorubicin—TOP2B—eye—leprosy	0.000878	0.0594	CbGeAlD
Daunorubicin—Affect lability—Thalidomide—leprosy	0.000876	0.00926	CcSEcCtD
Daunorubicin—CYP1A1—skin epidermis—leprosy	0.000858	0.0581	CbGeAlD
Daunorubicin—Cardiac arrest—Thalidomide—leprosy	0.000846	0.00894	CcSEcCtD
Daunorubicin—Mood swings—Thalidomide—leprosy	0.000843	0.00891	CcSEcCtD
Daunorubicin—Ataxia—Thalidomide—leprosy	0.000837	0.00884	CcSEcCtD
Daunorubicin—Tachycardia—Dapsone—leprosy	0.000834	0.00881	CcSEcCtD
Daunorubicin—Dehydration—Thalidomide—leprosy	0.000828	0.00875	CcSEcCtD
Daunorubicin—Dry skin—Thalidomide—leprosy	0.000816	0.00862	CcSEcCtD
Daunorubicin—TOP2A—Menadione—Thalidomide—leprosy	0.000796	0.139	CbGdCrCtD
Daunorubicin—Insomnia—Dapsone—leprosy	0.000773	0.00817	CcSEcCtD
Daunorubicin—Dysphagia—Thalidomide—leprosy	0.000769	0.00813	CcSEcCtD
Daunorubicin—NR5A1—testis—leprosy	0.000757	0.0512	CbGeAlD
Daunorubicin—Angina pectoris—Thalidomide—leprosy	0.000749	0.00792	CcSEcCtD
Daunorubicin—NR5A1—nervous system—leprosy	0.000743	0.0502	CbGeAlD
Daunorubicin—Pancytopenia—Thalidomide—leprosy	0.000731	0.00772	CcSEcCtD
Daunorubicin—Neutropenia—Thalidomide—leprosy	0.000719	0.0076	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dapsone—leprosy	0.000699	0.00738	CcSEcCtD
Daunorubicin—Depression—Thalidomide—leprosy	0.000684	0.00723	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Thalidomide—leprosy	0.000676	0.00715	CcSEcCtD
Daunorubicin—Body temperature increased—Dapsone—leprosy	0.000676	0.00714	CcSEcCtD
Daunorubicin—Abdominal pain—Dapsone—leprosy	0.000676	0.00714	CcSEcCtD
Daunorubicin—Renal failure—Thalidomide—leprosy	0.000674	0.00713	CcSEcCtD
Daunorubicin—Myocardial infarction—Thalidomide—leprosy	0.000672	0.00711	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Thalidomide—leprosy	0.000672	0.00711	CcSEcCtD
Daunorubicin—Stomatitis—Thalidomide—leprosy	0.000669	0.00707	CcSEcCtD
Daunorubicin—Conjunctivitis—Thalidomide—leprosy	0.000667	0.00705	CcSEcCtD
Daunorubicin—Sinusitis—Thalidomide—leprosy	0.000644	0.0068	CcSEcCtD
Daunorubicin—Rhinitis—Thalidomide—leprosy	0.000617	0.00652	CcSEcCtD
Daunorubicin—YWHAG—tendon—leprosy	0.000604	0.0408	CbGeAlD
Daunorubicin—Visual impairment—Thalidomide—leprosy	0.000593	0.00627	CcSEcCtD
Daunorubicin—TOP2B—tendon—leprosy	0.000582	0.0394	CbGeAlD
Daunorubicin—Tinnitus—Thalidomide—leprosy	0.000574	0.00607	CcSEcCtD
Daunorubicin—Cardiac disorder—Thalidomide—leprosy	0.000572	0.00604	CcSEcCtD
Daunorubicin—Chills—Thalidomide—leprosy	0.000553	0.00584	CcSEcCtD
Daunorubicin—Arrhythmia—Thalidomide—leprosy	0.00055	0.00581	CcSEcCtD
Daunorubicin—Alopecia—Thalidomide—leprosy	0.000544	0.00575	CcSEcCtD
Daunorubicin—Vomiting—Dapsone—leprosy	0.000543	0.00574	CcSEcCtD
Daunorubicin—Headache—Dapsone—leprosy	0.000535	0.00566	CcSEcCtD
Daunorubicin—Dysgeusia—Thalidomide—leprosy	0.000525	0.00555	CcSEcCtD
Daunorubicin—Back pain—Thalidomide—leprosy	0.000519	0.00548	CcSEcCtD
Daunorubicin—Nausea—Dapsone—leprosy	0.000508	0.00536	CcSEcCtD
Daunorubicin—Tremor—Thalidomide—leprosy	0.000502	0.00531	CcSEcCtD
Daunorubicin—YWHAG—testis—leprosy	0.0005	0.0338	CbGeAlD
Daunorubicin—Ill-defined disorder—Thalidomide—leprosy	0.000497	0.00526	CcSEcCtD
Daunorubicin—Anaemia—Thalidomide—leprosy	0.000496	0.00524	CcSEcCtD
Daunorubicin—Agitation—Thalidomide—leprosy	0.000493	0.00521	CcSEcCtD
Daunorubicin—YWHAG—nervous system—leprosy	0.000491	0.0332	CbGeAlD
Daunorubicin—Malaise—Thalidomide—leprosy	0.000483	0.00511	CcSEcCtD
Daunorubicin—TOP2B—testis—leprosy	0.000482	0.0326	CbGeAlD
Daunorubicin—Syncope—Thalidomide—leprosy	0.000481	0.00508	CcSEcCtD
Daunorubicin—Leukopenia—Thalidomide—leprosy	0.00048	0.00507	CcSEcCtD
Daunorubicin—ABCB11—testis—leprosy	0.000476	0.0322	CbGeAlD
Daunorubicin—Palpitations—Thalidomide—leprosy	0.000474	0.00501	CcSEcCtD
Daunorubicin—TOP2B—nervous system—leprosy	0.000473	0.032	CbGeAlD
Daunorubicin—Loss of consciousness—Thalidomide—leprosy	0.000471	0.00498	CcSEcCtD
Daunorubicin—Cough—Thalidomide—leprosy	0.000468	0.00494	CcSEcCtD
Daunorubicin—Convulsion—Thalidomide—leprosy	0.000464	0.00491	CcSEcCtD
Daunorubicin—Hypertension—Thalidomide—leprosy	0.000463	0.00489	CcSEcCtD
Daunorubicin—POR—tendon—leprosy	0.000459	0.0311	CbGeAlD
Daunorubicin—Chest pain—Thalidomide—leprosy	0.000456	0.00482	CcSEcCtD
Daunorubicin—Myalgia—Thalidomide—leprosy	0.000456	0.00482	CcSEcCtD
Daunorubicin—Arthralgia—Thalidomide—leprosy	0.000456	0.00482	CcSEcCtD
Daunorubicin—Anxiety—Thalidomide—leprosy	0.000455	0.00481	CcSEcCtD
Daunorubicin—Discomfort—Thalidomide—leprosy	0.000451	0.00476	CcSEcCtD
Daunorubicin—Dry mouth—Thalidomide—leprosy	0.000446	0.00472	CcSEcCtD
Daunorubicin—Confusional state—Thalidomide—leprosy	0.000441	0.00466	CcSEcCtD
Daunorubicin—Oedema—Thalidomide—leprosy	0.000438	0.00462	CcSEcCtD
Daunorubicin—Infection—Thalidomide—leprosy	0.000435	0.00459	CcSEcCtD
Daunorubicin—CYP1B1—eye—leprosy	0.000432	0.0293	CbGeAlD
Daunorubicin—Shock—Thalidomide—leprosy	0.00043	0.00455	CcSEcCtD
Daunorubicin—Thrombocytopenia—Thalidomide—leprosy	0.000428	0.00453	CcSEcCtD
Daunorubicin—TOP2A—tendon—leprosy	0.000428	0.0289	CbGeAlD
Daunorubicin—Tachycardia—Thalidomide—leprosy	0.000427	0.00451	CcSEcCtD
Daunorubicin—Hyperhidrosis—Thalidomide—leprosy	0.000423	0.00447	CcSEcCtD
Daunorubicin—Anorexia—Thalidomide—leprosy	0.000417	0.00441	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000399	0.00421	CcSEcCtD
Daunorubicin—Insomnia—Thalidomide—leprosy	0.000396	0.00418	CcSEcCtD
Daunorubicin—Dyspnoea—Thalidomide—leprosy	0.00039	0.00412	CcSEcCtD
Daunorubicin—Somnolence—Thalidomide—leprosy	0.000389	0.00411	CcSEcCtD
Daunorubicin—Decreased appetite—Thalidomide—leprosy	0.00038	0.00402	CcSEcCtD
Daunorubicin—POR—testis—leprosy	0.00038	0.0257	CbGeAlD
Daunorubicin—Fatigue—Thalidomide—leprosy	0.000377	0.00399	CcSEcCtD
Daunorubicin—CYP1B1—skin of body—leprosy	0.000376	0.0255	CbGeAlD
Daunorubicin—Constipation—Thalidomide—leprosy	0.000374	0.00395	CcSEcCtD
Daunorubicin—Pain—Thalidomide—leprosy	0.000374	0.00395	CcSEcCtD
Daunorubicin—ABCC10—tendon—leprosy	0.000364	0.0246	CbGeAlD
Daunorubicin—Feeling abnormal—Thalidomide—leprosy	0.000361	0.00381	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Thalidomide—leprosy	0.000358	0.00378	CcSEcCtD
Daunorubicin—TOP2A—testis—leprosy	0.000354	0.024	CbGeAlD
Daunorubicin—Urticaria—Thalidomide—leprosy	0.000348	0.00367	CcSEcCtD
Daunorubicin—Body temperature increased—Thalidomide—leprosy	0.000346	0.00365	CcSEcCtD
Daunorubicin—Abdominal pain—Thalidomide—leprosy	0.000346	0.00365	CcSEcCtD
Daunorubicin—Hypersensitivity—Thalidomide—leprosy	0.000322	0.00341	CcSEcCtD
Daunorubicin—Asthenia—Thalidomide—leprosy	0.000314	0.00332	CcSEcCtD
Daunorubicin—Pruritus—Thalidomide—leprosy	0.00031	0.00327	CcSEcCtD
Daunorubicin—ABCC10—testis—leprosy	0.000302	0.0204	CbGeAlD
Daunorubicin—Diarrhoea—Thalidomide—leprosy	0.000299	0.00316	CcSEcCtD
Daunorubicin—ABCB1—blood vessel—leprosy	0.000298	0.0202	CbGeAlD
Daunorubicin—ABCC2—tendon—leprosy	0.000292	0.0198	CbGeAlD
Daunorubicin—Dizziness—Thalidomide—leprosy	0.000289	0.00306	CcSEcCtD
Daunorubicin—CYP1B1—tendon—leprosy	0.000286	0.0194	CbGeAlD
Daunorubicin—Vomiting—Thalidomide—leprosy	0.000278	0.00294	CcSEcCtD
Daunorubicin—Rash—Thalidomide—leprosy	0.000276	0.00291	CcSEcCtD
Daunorubicin—Dermatitis—Thalidomide—leprosy	0.000276	0.00291	CcSEcCtD
Daunorubicin—Headache—Thalidomide—leprosy	0.000274	0.0029	CcSEcCtD
Daunorubicin—CYP1A1—skin of body—leprosy	0.000266	0.018	CbGeAlD
Daunorubicin—Nausea—Thalidomide—leprosy	0.00026	0.00275	CcSEcCtD
Daunorubicin—ABCC1—tendon—leprosy	0.000258	0.0174	CbGeAlD
Daunorubicin—ABCC2—testis—leprosy	0.000242	0.0164	CbGeAlD
Daunorubicin—CYP1B1—testis—leprosy	0.000237	0.016	CbGeAlD
Daunorubicin—CYP1B1—nervous system—leprosy	0.000233	0.0157	CbGeAlD
Daunorubicin—ABCC1—testis—leprosy	0.000213	0.0144	CbGeAlD
Daunorubicin—ABCG2—testis—leprosy	0.000177	0.0119	CbGeAlD
Daunorubicin—CYP1A1—nervous system—leprosy	0.000165	0.0111	CbGeAlD
Daunorubicin—CYP3A4—nervous system—leprosy	0.000121	0.00817	CbGeAlD
Daunorubicin—ABCB1—testis—leprosy	8.71e-05	0.00589	CbGeAlD
Daunorubicin—ABCB1—nervous system—leprosy	8.55e-05	0.00578	CbGeAlD
